Search by Drug Name or NDC
NDC 17478-0605-10 COSOPT 20; 5 mg/mL; mg/mL Details
COSOPT 20; 5 mg/mL; mg/mL
COSOPT is a OPHTHALMIC SOLUTION/ DROPS in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Akorn. The primary component is DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE.
MedlinePlus Drug Summary
The combination of dorzolamide and timolol is used to treat eye conditions, including glaucoma and ocular hypertension, in which increased pressure can lead to a gradual loss of vision. Dorzolamide and timolol is used for patients whose eye condition has not responded to another medication. Dorzolamide is in a class of medications called topical carbonic anhydrase inhibitors. Timolol is in a class of medications called topical beta blockers. Dorzolamide and timolol lowers pressure in the eye by decreasing the production of natural fluids in the eye.
Related Packages: 17478-0605-10Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Dorzolamide and Timolol Ophthalmic
Product Information
| NDC | 17478-0605 |
|---|---|
| Product ID | 17478-605_f5ba2fb3-cce3-4b06-973b-9286b018a4d3 |
| Associated GPIs | 86259902202020 |
| GCN Sequence Number | 039531 |
| GCN Sequence Number Description | dorzolamide HCl/timolol maleat DROPS 22.3-6.8/1 OPHTHALMIC |
| HIC3 | Q6G |
| HIC3 Description | MIOTICS AND OTHER INTRAOCULAR PRESSURE REDUCERS |
| GCN | 95919 |
| HICL Sequence Number | 018269 |
| HICL Sequence Number Description | DORZOLAMIDE HCL/TIMOLOL MALEATE |
| Brand/Generic | Brand |
| Proprietary Name | COSOPT |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dorzolamide Hydrochloride and Timolol Maleate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Active Ingredient Strength | 20; 5 |
| Active Ingredient Units | mg/mL; mg/mL |
| Substance Name | DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE |
| Labeler Name | Akorn |
| Pharmaceutical Class | Adrenergic beta-Antagonists [MoA], Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], beta-Adrenergic Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA020869 |
| Listing Certified Through | 2022-12-31 |
Package
NDC 17478-0605-10 (17478060510)
| NDC Package Code | 17478-605-10 |
|---|---|
| Billing NDC | 17478060510 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (17478-605-10) / 10 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2014-04-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |